276 related articles for article (PubMed ID: 23077236)
1. Localization and identification of sumoylated proteins in human sperm: excessive sumoylation is a marker of defective spermatozoa.
Vigodner M; Shrivastava V; Gutstein LE; Schneider J; Nieves E; Goldstein M; Feliciano M; Callaway M
Hum Reprod; 2013 Jan; 28(1):210-23. PubMed ID: 23077236
[TBL] [Abstract][Full Text] [Related]
2. SUMO1 in human sperm: new targets, role in motility and morphology and relationship with DNA damage.
Marchiani S; Tamburrino L; Ricci B; Nosi D; Cambi M; Piomboni P; Belmonte G; Forti G; Muratori M; Baldi E
Reproduction; 2014 Nov; 148(5):453-67. PubMed ID: 25118297
[TBL] [Abstract][Full Text] [Related]
3. Identification of small ubiquitin-like modifier substrates with diverse functions using the Xenopus egg extract system.
Ma L; Aslanian A; Sun H; Jin M; Shi Y; Yates JR; Hunter T
Mol Cell Proteomics; 2014 Jul; 13(7):1659-75. PubMed ID: 24797264
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
6. SUMO proteins are involved in the stress response during spermatogenesis and are localized to DNA double-strand breaks in germ cells.
Shrivastava V; Pekar M; Grosser E; Im J; Vigodner M
Reproduction; 2010 Jun; 139(6):999-1010. PubMed ID: 20385780
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
8. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
9. Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies.
Barysch SV; Dittner C; Flotho A; Becker J; Melchior F
Nat Protoc; 2014 Apr; 9(4):896-909. PubMed ID: 24651501
[TBL] [Abstract][Full Text] [Related]
10. Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation.
Qi Y; Guan H; Liang X; Sun J; Yao W
Cardiovasc Drugs Ther; 2021 Aug; 35(4):769-773. PubMed ID: 33891248
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques.
Wagner T; Godmann M; Heinzel T
Methods Mol Biol; 2017; 1510():339-351. PubMed ID: 27761833
[TBL] [Abstract][Full Text] [Related]
12. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
Sriramachandran AM; Meyer-Teschendorf K; Pabst S; Ulrich HD; Gehring NH; Hofmann K; Praefcke GJK; Dohmen RJ
Nat Commun; 2019 Aug; 10(1):3678. PubMed ID: 31417085
[TBL] [Abstract][Full Text] [Related]
13. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
Cuijpers SAG; Willemstein E; Vertegaal ACO
Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
[TBL] [Abstract][Full Text] [Related]
14. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.
Impens F; Radoshevich L; Cossart P; Ribet D
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12432-7. PubMed ID: 25114211
[TBL] [Abstract][Full Text] [Related]
15. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
16. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.
Matic I; van Hagen M; Schimmel J; Macek B; Ogg SC; Tatham MH; Hay RT; Lamond AI; Mann M; Vertegaal ACO
Mol Cell Proteomics; 2008 Jan; 7(1):132-44. PubMed ID: 17938407
[TBL] [Abstract][Full Text] [Related]
17. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
Wu YC; Roark AA; Bian XL; Wilson VG
Virology; 2008 Sep; 378(2):329-38. PubMed ID: 18619639
[TBL] [Abstract][Full Text] [Related]
18. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
Hirano S; Tadano M; Kobayashi Y; Udagawa O; Kato A
Toxicol Appl Pharmacol; 2015 Sep; 287(3):191-201. PubMed ID: 26049103
[TBL] [Abstract][Full Text] [Related]
19. Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.
Gilbreth RN; Truong K; Madu I; Koide A; Wojcik JB; Li NS; Piccirilli JA; Chen Y; Koide S
Proc Natl Acad Sci U S A; 2011 May; 108(19):7751-6. PubMed ID: 21518904
[TBL] [Abstract][Full Text] [Related]
20. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
